SCHEMBL5088786

SCHEMBL5088786

CCCCN(CCCC)C(=O)Cc1ccc(N)c(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
APEX1 P27695 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
GAA P10253 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
LTB4R2 Q9NPC1 1/20 0.42
CNR2 P34972 2/20 0.41
MC4R P32245 1/20 0.41
MC3R P41968 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
PPARA Q07869 1/20 0.40
SKP2 Q13309 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5094934 0.91 POLB (0.56) POLBAPEX1TDP1GAAKDM4E
SCHEMBL5430063 0.87 POLB (0.46) POLBAPEX1TDP1GAAKDM4E
SCHEMBL5086740 0.85 GAA (0.50) POLBAPEX1TDP1GAAKDM4E
SCHEMBL5088874 0.84 GAA (0.49) POLBAPEX1TDP1GAAKDM4E
Phosphoric Acid SCHEMBL5430756 0.80 GAA (0.45) POLBAPEX1TDP1GAAKDM4E
SCHEMBL5094928 0.79 GAA (0.53) POLBAPEX1TDP1GAAKDM4E
SCHEMBL5162643 0.77 CYP1A2 (0.45) POLBAPEX1TDP1CYP1A2CYP3A4
SCHEMBL5482008 0.75 SKP2 (0.58) POLBGAAKDM4EMEN1MAPT
SCHEMBL5086794 0.75 GAA (0.49) POLBAPEX1TDP1GAAKDM4E
SCHEMBL5088894 0.74 TRPV1 (0.68) POLBGAAKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2008510738-A 2008-04-10 JP claimed
EP-1781597-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-05-09 EP claimed
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US claimed
WO-2006021256-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-03-02 WO claimed
EP-1781597-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2007-05-09 EP disclosed
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 US disclosed
WO-2006021256-A1 O-AMINOPHENOL DERIVATIVES AND DYES CONTAINING THESE COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099959-A1 O-Aminophenol derivatives and colorants containing these compounds KRT18, TYR, ALPG POLB 1283/4885APEX1 2354/4885TDP1 3603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.